Sartorius AG (SOAGY)
58.84
+1.68
(+2.94%)
USD |
OTCM |
Aug 27, 16:00
Sartorius Net Income (Quarterly) : 107.78M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 107.78M |
| March 31, 2026 | 94.76M |
| December 31, 2025 | 51.21M |
| September 30, 2025 | 72.45M |
| June 30, 2025 | 58.71M |
| March 31, 2025 | 76.41M |
| December 31, 2024 | 24.21M |
| September 30, 2024 | 24.72M |
| June 30, 2024 | 41.45M |
| March 31, 2024 | 57.96M |
| December 31, 2023 | 13.33M |
| September 30, 2023 | 26.87M |
| June 30, 2023 | 142.03M |
| March 31, 2023 | 131.97M |
| December 31, 2022 | 209.11M |
| September 30, 2022 | 206.19M |
| June 30, 2022 | 236.69M |
| March 31, 2022 | 310.97M |
| December 31, 2021 | 27.52M |
| September 30, 2021 | 170.11M |
| June 30, 2021 | 180.82M |
| March 31, 2021 | 151.16M |
| December 31, 2020 | 108.44M |
| September 30, 2020 | 110.92M |
| June 30, 2020 | 57.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 71.72M |
| December 31, 2019 | 55.07M |
| September 30, 2019 | 60.71M |
| June 30, 2019 | 69.22M |
| March 31, 2019 | 59.84M |
| December 31, 2018 | 77.68M |
| September 30, 2018 | 55.13M |
| June 30, 2018 | 52.76M |
| March 31, 2018 | 46.33M |
| December 31, 2017 | 68.79M |
| September 30, 2017 | 37.91M |
| June 30, 2017 | 33.78M |
| March 31, 2017 | 40.59M |
| December 31, 2016 | 34.38M |
| September 30, 2016 | 43.51M |
| June 30, 2016 | 44.70M |
| March 31, 2016 | 37.93M |
| December 31, 2015 | 26.59M |
| September 30, 2015 | 44.78M |
| June 30, 2015 | 37.20M |
| March 31, 2015 | 21.61M |
| December 31, 2014 | 18.99M |
| September 30, 2014 | 24.16M |
| June 30, 2014 | 21.43M |
| March 31, 2014 | 19.99M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Mesa Laboratories, Inc. | 2.83M |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | 45.32M |
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.060B |
| Total Expenses (Quarterly) | 983.54M |
| EPS Diluted (Quarterly) | 0.2219 |
| Enterprise Value | 15.89B |
| Gross Profit Margin (Quarterly) | 47.50% |
| Profit Margin (Quarterly) | 10.17% |
| Earnings Yield | 1.13% |
| Operating Earnings Yield | 3.64% |
| Normalized Earnings Yield | 1.355 |